Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability

Journal of Cell Science

Volumn 115, Issue 12, 2002, Pages 2559-2567

  Odorisio, Teresa ^a   Schietroma, Cataldo ^a   Zaccaria, M Letizia ^a   Cianfarani, Francesca ^a   Tiveron, Cecilia ^a   Talangelo, Laura ^a   Failla, Cristina M ^a   Zambruno, Giovanna ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Angiogenesis; PIGF; Transgenic mice; VEGF; Vessel permeability

Indexed keywords

CYTOKINE; KERATIN; PLACENTAL GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CD31 ANTIGEN; CYTOKERATIN 14; DIAGNOSTIC AGENT; FLTN PROTEIN, MOUSE; HYBRID PROTEIN; KRT1 14 PROTEIN, MOUSE; KRT1-14 PROTEIN, MOUSE; MESSENGER RNA; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; SCLEROPROTEIN; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; GENE CASSETTE; GENE FUNCTION; GENE OVEREXPRESSION; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SKIN BLOOD VESSEL; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASCULARIZATION; WILD TYPE; ANIMAL; ANIMAL MODEL; CAPILLARY PERMEABILITY; CELL CULTURE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; NEWBORN; PHYSIOLOGY; SKIN; UPREGULATION;

ANIMAL; ANIMALS, NEWBORN; ANTIGENS, CD31; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KERATIN; MALE; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SKIN; SUPPORT, NON-U.S. GOV'T; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; ANIMALS; KERATIN-14; KERATINS;

ANIMALIA; MUS MUSCULUS;

EID: 0037096168     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Heterodimers of placenta growth factor/vascular endothelial growth factor
2. Mechanisms of angiogenesis and arteriogenesis
3. Angiogenesis in cancer and other diseases
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
6. The vascular endothelial growth factor receptor Flt-1 mediates biological activities
7. Endothelial cell-to-cell junctions
8. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
9. Purification and characterization of a naturally occurring vascular endothelial growth factor-placenta growth factor heterodimer
10. Expression and localization of placenta growth factor and PIGF receptors in human meningiomas
11. Placenta growth factor is induced in human keratinocytes during wound healing
12. Vascular endothelial growth factor: Molecular and biological aspects
13. The biology of vascular endothelial growth factor
14. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
15. VEGF is required for growth and survival in neonatal mice
16. Long-term culture of murine epidermal keratinocytes
17. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas
18. Expression of vascular endothelial growth factor receptors in smooth muscle cells
19. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
20. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
21. In vitro RNA synthesis with SP6 RNA polymerase
22. Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor
23. Flow velocity in the superficial lymphatic network of the mouse tail
24. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli
25. Placenta growth factor (PIGF) mRNA expression in brain tumors
26. Transcriptional analysis of the candidate spermatogenesis gene Ube 1y and the closely related Ube1x shows that they are coexpressed in spermatogonia and spermatids but are repressed in pachytene spermatocytes
27. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
28. Structure, expression, and receptor-binding properties of placenta growth factor (PIGF)
29. Mechanisms of angiogenesis
30. Structure, function, and molecular control of the skin lymphatic system
31. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
32. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
33. Identification of receptor genes in renal carcinoma associated with angiogenesis by differential hybridization technique
34. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding
35. Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences
36. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
37. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice
38. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Role of flt-1
39. Vascular-specific growth factors and blood vessel formation
40. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic